Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

125.66
Delayed Data
As of 3:59pm ET
 +2.64 / +2.15%
Today’s Change
84.97
Today|||52-Week Range
167.33
+9.11%
Year-to-Date

Today’s Trading

Previous close123.02
Today’s open125.05
Day’s range123.33 - 127.91
Volume24,013
Average volume (3 months)505,606
Market cap$14.5B
Data as of 3:59pm ET, 11/24/2020

Growth & Valuation

Earnings growth (last year)-7.13%
Earnings growth (this year)+12.98%
Earnings growth (next 5 years)+89.28%
Revenue growth (last year)+193.36%
P/E ratioNM
Price/Sales57.26
Price/Book9.72

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Therapeutics...-1.02-1.46%
----
CTLTCatalent Inc-5.15-5.16%
MRTXMirati Therapeutics ...-1.97-0.88%
Data as of 4:00pm ET, 11/24/2020

Financials

Next reporting dateFebruary 11, 2021
EPS forecast (this quarter)-$1.72
Annual revenue (last year)$219.8M
Annual profit (last year)-$886.1M
Net profit margin-403.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts